What does CRV stand for?

Although a laser treatment of the retina called grid photocoagulation has shown a benefit in improving the vision of patients with blockages in smaller branches of the retinal vein, there is presently no effective therapy for vision loss associated with macular edema after central retinal vein occlusion-blockage in the main portion of the retinal vein, at the optic nerve.

Nasdaq:REGN) have announced that the companies are extending their global development program for VEGF Trap-Eye, an investigational agent for the treatment of certain eye diseases, to include Central Retinal Vein Occlusion (CRVO).

Gerring suffers from central retinal vein occlusion -- a blockage of circulation that drains blood from the retina -- which occurs with much higher frequency in people over 65.

Amanda was suffering from central retinal vein occlusion.

a wholly-owned member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the Phase III study CRUISE showed Lucentis([R])(ranibizumab injection) improved vision, as measured by the primary endpoint of mean change from baseline in best-corrected visual acuity at six months, in patients with macular edema due to central retinal vein occlusion.

NASDAQ:REGN) today announced that the first patient has been enrolled in the Phase 3 program of VEGF Trap-Eye for the treatment of central retinal vein occlusion (CRVO), a leading cause of blindness in adults.

7 mg as the first drug therapy indicated for the treatment of macular edema following branch retinal vein occlusion (BRVO) or central retinal vein occlusion (CRVO).

VEGF Trap-Eye - Ophthalmologic Diseases VEGF Trap-Eye is a specially purified and formulated form of VEGF Trap for use in intraocular applications that is being developed by Regeneron and its collaborator, Bayer HealthCare, for the treatment of the neovascular form of Age-related Macular Degeneration (wet AMD), Diabetic Macular Edema (DME), Central Retinal Vein Occlusion (CRVO), and other eye diseases and disorders.